LON:STX Shield Therapeutics (STX) Share Price, News & Analysis GBX 5.02 -0.18 (-3.46%) (As of 12:13 PM ET) Add Compare Share Share Today's Range 5.02▼ 5.5050-Day Range 1.55▼ 5.3452-Week Range 1.06▼ 12.85Volume3.24 million shsAverage Volume5.11 million shsMarket Capitalization£39.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Shield Therapeutics alerts: Email Address Ad Chaikin AnalyticsSell NVDA Now?Just weeks before last month’s selloff, Citadel – the most successful hedge fund in history – quietly sold 500,000 shares. DE Shaw, which once owned over $1 billion of Nvidia stock , slashed its position by half . The stock has since plunged nearly 10%. What’s happening to what was once Wall Street’s favorite company?What does it mean for your money? About Shield Therapeutics Stock (LON:STX)Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.Read More STX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STX Stock News HeadlinesSeptember 5, 2024 | americanbankingnews.comShield Therapeutics (LON:STX) Shares Up 7.8%September 4, 2024 | msn.comShield Therapeutics builds revenues as US prescriptions growSeptember 9, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.September 4, 2024 | americanbankingnews.comShield Therapeutics (LON:STX) Stock Price Down 7.5%August 28, 2024 | msn.comShield Therapeutics to enter Canadian market following approval of iron deficiency drugJuly 24, 2024 | msn.comBoss of drugs firm Shield Therapeutics steps down as US prescriptions ramp upJuly 24, 2024 | markets.businessinsider.comShield Therapeutics CEO Greg Madison To Step DownMay 28, 2024 | msn.comKorean market is latest play for Shield Therapeutics' iron deficiency drugSeptember 9, 2024 | Golden Crest (Ad)Biden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.May 9, 2024 | finance.yahoo.comInsider Traders Lose US$91k As Shield Therapeutics DropsMay 3, 2024 | msn.comGalera Therapeutics Implements Stockholder Rights Plan to Shield Investor InterestsMay 2, 2024 | msn.comTurning a tumor's 'shield' into a weapon against itselfApril 10, 2024 | msn.comNeutral Switzerland joins European Sky Shield defence projectApril 1, 2024 | tmcnet.comAmerican Home Shield Offering 40% Off ShieldGold™ For Limited TimeMarch 29, 2024 | msn.comA Real Life Invisibility Shield for Privacy in Public PlacesMarch 11, 2024 | tmcnet.comSeal Shield to Showcase Shyld AI, the World's First Intelligent, Autonomous, UV-C Disinfection System at HIMSS 2024February 23, 2024 | lse.co.ukLONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutesFebruary 22, 2024 | morningstar.comShield Therapeutics PLC STXSee More Headlines Receive STX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryComputer Hardware Current SymbolLON:STX CUSIPN/A CIKN/A Webwww.shieldtherapeutics.com Phone+44-191-5118500FaxN/AEmployees40,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.04) Trailing P/E RatioN/A Forward P/E Ratio63.10 P/E GrowthN/ANet Income£-33,290,000.00 Net Margins-254.44% Pretax MarginN/A Return on Equity-308.60% Return on Assets-51.93% Debt Debt-to-Equity Ratio134.67 Current Ratio2.28 Quick Ratio2.16 Sales & Book Value Annual Sales£13.09 million Price / Sales3.00 Cash FlowGBX 0.79 per share Price / Cash Flow6.36 Book ValueGBX 2 per share Price / Book2.51Miscellaneous Outstanding Shares782,060,000Free FloatN/AMarket Cap£39.26 million OptionableNot Optionable Beta1.42 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Gregory P. Madison (Age 57)CEO & Executive Director Comp: $678kDr. Christian Schweiger M.D. (Age 58)Ph.D., Co-Founder & Non Executive Director Comp: $45kMr. Santosh Shanbhag (Age 46)Chief Financial Officer Ms. Lucy Kate Huntington-BaileyGeneral Counsel & Company SecretaryMs. Suzanne WoodGroup HR DirectorMs. Carol AkinolaHead of Pharmacovigilance & Medical InformationMr. Andrew Hurley (Age 55)Chief Commercial Officer Kate ArmanettiSenior Director of People & CultureMore ExecutivesKey CompetitorsEl OroLON:ELXApc Technology GroupLON:APCDG InnovateLON:DGIStreaksAILON:STKIdeagenLON:IDEAView All Competitors STX Stock Analysis - Frequently Asked Questions How have STX shares performed this year? Shield Therapeutics' stock was trading at GBX 6.70 at the beginning of the year. Since then, STX stock has decreased by 25.1% and is now trading at GBX 5.02. View the best growth stocks for 2024 here. How do I buy shares of Shield Therapeutics? Shares of STX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Shield Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shield Therapeutics investors own include AcelRx Pharmaceuticals (ACRX), Rockwell Medical (RMTI), Cara Therapeutics (CARA), Caladrius Biosciences (CLBS), Cellectis (CLLS), Geron (GERN) and Concepta PLC (CPT.L) (CPT). This page (LON:STX) was last updated on 9/9/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredSell NVDA Now?Just weeks before last month’s selloff, Citadel – the most successful hedge fund in history – quietly sold 500...Chaikin Analytics | Sponsored‘Wheels Are Falling Off’ the U.S. Stock Market"Wheels Are Falling Off" The U.S. Stock Market Today, analyst Dan Ferris is back issuing a new warning. He ...Stansberry Research | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredCan Apple’s AI News Make You Rich?September 20th 2024: AI’s “iPhone Moment” Apple is making a major move on Friday, September 20th. And what ...Banyan Hill Publishing | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shield Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Shield Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
